• AICAR Phosphate (Acadesine): Applied Workflows in B-CLL Rese

  2026-04-20

  Explore how AICAR phosphate (Acadesine) empowers apoptosis studies in B-cell chronic lymphocytic leukemia (B-CLL) and beyond, with optimized experimental protocols and troubleshooting strategies. This guide bridges mechanistic insight with actionable workflows, leveraging APExBIO’s high-purity reagent for reproducible and robust cancer research.

• Tropifexor (LJN452): Precision FXR Modulation in Barrier & M

  2026-04-20

  Tropifexor (LJN452) offers ultra-potent, reproducible FXR pathway activation for metabolic and intestinal epithelial barrier research. This guide translates bench data into applied protocols and troubleshooting strategies, leveraging APExBIO’s trusted quality for high-impact experimental outcomes.

• DMH1: Precision ALK2 Inhibition for Organoid and NSCLC Resea

  2026-04-19

  DMH1 empowers researchers to fine-tune BMP signaling, enabling robust control over stem cell fate and tumor proliferation in both organoid engineering and non-small cell lung cancer workflows. This guide delivers actionable protocols, troubleshooting insights, and contextualizes the latest evidence for maximizing DMH1's impact in advanced cellular models.

• Sorafenib (BAY-43-9006): Applied Workflows in Cancer Biology

  2026-04-18

  Sorafenib (BAY-43-9006) is a powerful multikinase inhibitor used to dissect tumor signaling and antiangiogenic mechanisms across diverse cancer models. This guide delivers actionable protocols, troubleshooting strategies, and real-world applications, making it indispensable for translational cancer biology research.

• Z-VAD-FMK: Translating Caspase Inhibition into Cancer Insigh

  2026-04-17

  This thought-leadership article unpacks the mechanistic and strategic value of Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone) for translational researchers targeting apoptosis and cell death pathways. We bridge new findings on non-apoptotic cancer cell death modalities from redox-active vitamin C studies with the practical deployment of APExBIO’s Z-VAD-FMK, offering advanced protocol guidance and a roadmap for leveraging caspase inhibition in high-impact cancer research.

• METTL14-m6A-lncRNA Axis Modulates Colitis Inflammation

  2026-04-16

  This study reveals how METTL14-mediated m6A modification of the lncRNA DHRS4-AS1 regulates inflammation in ulcerative colitis by modulating the miR-206/A3AR axis. These findings expand our mechanistic understanding of epigenetic regulation in inflammatory bowel disease and suggest new experimental models for targeting RNA methylation pathways.

• rTMS Promotes Cognitive Recovery in Alzheimer’s via Cx3cl1-C

  2026-04-15

  This study demonstrates that repetitive transcranial magnetic stimulation (rTMS) enhances cognitive recovery in Alzheimer’s disease by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 signaling axis, which in turn boosts microglial amyloid clearance. These findings highlight a non-invasive therapeutic strategy and clarify molecular mechanisms, supporting the translation of rTMS approaches in Alzheimer’s disease research.

• Dual SMAD and Wnt Inhibition Drives Efficient iPSC to RGC Di

  2026-04-14

  This study demonstrates that simultaneous inhibition of SMAD and Wnt pathways enables highly efficient and reproducible differentiation of human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) without genetic modification. The protocol addresses previous variability and yield challenges, offering a robust platform to model optic neuropathies and potential regenerative therapies.

• VX-745: Advanced p38α MAPK Inhibitor for Inflammation Models

  2026-04-13

  VX-745 is redefining how researchers dissect p38 MAPK signaling, delivering nanomolar precision in suppressing IL-1β, TNF-α, and IL-6 secretion. Its dual-action mechanism and proven efficacy in both cellular and animal models empower studies of inflammation, drug resistance, and aging with unmatched specificity.

• ABT-737: BCL-2 Protein Inhibitor for Precision Apoptosis Ass

  2026-04-12

  ABT-737 unlocks robust, selective apoptosis induction in cancer and senescence models, offering reproducible performance for both basic and translational research. This guide details protocol enhancements, troubleshooting, and real-world applications, bridging new mechanistic insights with optimized workflows.

• Glucocorticoid Receptor Control of Brain CYPs Mitigates Phen

  2026-04-12

  This study uncovers that pregnenolone 16α-carbonitrile suppresses hippocampal cytochrome P450 enzymes and protects neurons from phenytoin-induced toxicity via a glucocorticoid receptor pathway, rather than the canonical PXR route. The findings highlight a previously unappreciated neurosteroid regulatory axis with implications for managing antiepileptic drug side effects.

• DiscoveryProbe Protease Inhibitor Library: Optimizing HTS an

  2026-04-11

  The DiscoveryProbe™ Protease Inhibitor Library empowers researchers to modulate diverse protease activities in high throughput and high content screening, streamlining drug discovery and mechanistic studies. Its validated, cell-permeable inhibitors and automation-ready format set it apart for robust, reproducible results in cancer, apoptosis, and infectious disease research.

• Troglitazone: PPARγ Agonist Workflows for Cancer & Diabetes

  2026-04-11

  Troglitazone’s role as a PPARγ agonist uniquely positions it for integrated metabolic and oncology workflows, enabling researchers to model both diabetes and tumor microenvironment modulation. This guide delivers stepwise protocols, troubleshooting insights, and actionable lessons from recent breakthroughs in targeting tumor-associated macrophages.

• Unlocking Translational Immunodetection: Mechanistic Adva...

  2026-04-10

  Discover how the Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO transforms human immunoglobulin detection for translational research. This thought-leadership article fuses mechanistic insights, evidence from cutting-edge orthopoxvirus antibody research, and practical strategies to maximize assay sensitivity and translational impact—going far beyond standard product pages.

• Faropenem Sodium (SKU C8712): Reliable Solutions for Anti...

  2026-04-09

  This scenario-driven guide addresses experimental challenges in cell viability, bacterial proliferation, and antimicrobial susceptibility assays, demonstrating how Faropenem sodium (SKU C8712) offers reproducibility, sensitivity, and workflow safety for advanced research. Drawing on validated data and real-world case analyses, biomedical scientists will learn best practices for leveraging Faropenem sodium as a broad-spectrum, β-lactamase-stable penem antibiotic in resistance and infection studies.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page